SOCIETE DE PROMOTION PHARMACEUTIQUE DU MAGHREB S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 930 MAD | +0.54% |
|
-4.73% | -7.00% |
| Sales 2021 | 630M 62.53M | Sales 2022 | 705M 69.89M | Capitalization | 1.07B 106M |
|---|---|---|---|---|---|
| Net income 2021 | 69M 6.84M | Net income 2022 | 75M 7.44M | EV / Sales 2021 | 1.48 x |
| Net cash position 2021 | 205M 20.34M | Net cash position 2022 | 56.78M 5.63M | EV / Sales 2022 | 1.44 x |
| P/E ratio 2021 |
16.5
x | P/E ratio 2022 |
14.2
x | Employees | - |
| Yield 2021 |
3.51% | Yield 2022 |
3.75% | Free-Float | 5.88% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +0.54% | ||
| 1 week | -4.73% | ||
| Current month | -1.59% | ||
| 1 month | -1.59% | ||
| 3 months | -6.91% | ||
| 6 months | -7.28% | ||
| Current year | -7.00% |
1 week
923.00
975.00
1 month
921.00976.20
Current year
921.001 008.00
1 year
921.001 110.00
3 years
800.001 226.00
5 years
690.001 226.00
10 years
634.001 690.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Said El Bouachi
DFI | Director of Finance/CFO | - | - |
Amine Alaoui
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ma’moun Araidah
CHM | Chairman | - | - |
Khalid Janahi
BRD | Director/Board Member | - | - |
Issam Maguiri
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 930 | +0.54% | 1 |
| 24-04-29 | 925 | +0.22% | 5 |
| 24-04-26 | 923 | -5.33% | 38 |
| 24-04-25 | 975 | -.--% | 5 |
| 24-04-24 | 975 | +3.61% | 24 |
End-of-day quote Casablanca S.E., April 29, 2024
More quotes
Promopharm (Société de Promotion Pharmaceutique du Maghreb) specializes in manufacturing and marketing pharmaceutical, para-pharmaceutical, and cosmetic products. The group also offers subcontractor manufacturing services for pharmaceutical specialties for Moroccan and foreign laboratories. The group's activity is organized primarily around 2 areas:
- sales of drugs: products manufactured under its own name and under license;
- importing and sales of semi-finished products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -7.00% | 91.84M | |
| +20.69% | 43.18B | |
| +20.67% | 22.59B | |
| +15.19% | 14.56B | |
| +42.72% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- PRO Stock
